Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01334164 · ClinicalTrials.gov registry record · Phase 2

Recovery Management Checkups for Women Offenders

A Phase 2 study of Recovery Management Checkup (RMC) and Outcome Monitoring, sponsored by Chestnut Health Systems.

Completed
Registry status
Phase 2
Development phase
480
Enrollment target
2
Study locations

NCT01334164: Completed Phase 2 study of Recovery Management Checkup (RMC) and Outcome Monitoring, sponsored by Chestnut Health Systems.

NCT01334164 is a Phase 2 study of Recovery Management Checkup (RMC) and Outcome Monitoring that has completed, run by Chestnut Health Systems. The registered enrollment target is 480 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (261% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01334164, a Phase 2 study of Recovery Management Checkup (RMC) and Outcome Monitoring, has completed, sponsored by Chestnut Health Systems.

COMPLETED
Registry status
Phase 2
Development phase
480 participants
Enrollment target
2
Study locations

Study Summary

The proposed study is designed to test the effectiveness of recovery management checkups for women offenders (RMC-WO) released from jail to provide continuity of care immediately upon release and to help them manage their long-term recovery. The hypotheses in the first phase were: 1)women assigned to RMC (versus control) will a) return to treatment sooner after the initial release from jail and b) be more likely to receive treatment in the 90 days after release from jail; 2)women who received treatment in the first 90 days post release (vs. no treatment) will be more likely to sustain their abstinence through 90 days post release from a) any alcohol or drugs, b) alcohol, c) cannabis, d) cocaine, and e) opiates; 3)women who maintained their abstinence from any alcohol and other drugs through the first 90 days post release (vs. any relapse) will be less likely to have a) unprotected sex, b) commit any other illegal activity, and d) be re-incarcerated in jail or prison. In the second phase repeated exposure to these efforts on a quarterly basis is expected to further strengthen each of these effects.

Primary Outcome

Time from first relapse (after release from jail) to first treatment re-entry measured in days and censored at the last observation.

Interventions

  • BEHAVIORAL Recovery Management Checkups
  • OTHER Outcome Monitoring

Study Locations (2)

Illinois

  • Chestnut Health Systems-Lighthouse Institute - Chicago
  • Chestnut Health Systems - Normal

Trial Details

FieldValue
Enrollment Target 480 participants
Start Date 2007-07
Est. Completion 2015-06
Phase Phase 2
Chestnut Health Systems

20 total trials

What the finished NCT01334164 record still lists

NCT01334164 is an interventional study that assigns participants to a tested intervention. The registered 480 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (261% higher).

The record links to 2 conditions, with Recovery Management Checkup (RMC) appearing as the primary indexed condition, and to 2 interventions - of which Recovery Management Checkups is the first listed.

NCT01334164 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT01334164 about?

NCT01334164 is a clinical study titled "Recovery Management Checkups for Women Offenders". The proposed study is designed to test the effectiveness of recovery management checkups for women offenders (RMC-WO) released from jail to provide continuity of care immediately upon release and to help them manage their long-term recovery. The hypotheses in the first phase were: 1)women assigned t...

What is the current status of trial NCT01334164?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 480 participants. The study started on 2007-07. Estimated completion is 2015-06.

What conditions does trial NCT01334164 study?

This clinical trial studies the following conditions: Recovery Management Checkup (RMC), Outcome Monitoring.

What interventions are being tested in trial NCT01334164?

The interventions under investigation include: Recovery Management Checkups (BEHAVIORAL), Outcome Monitoring (OTHER).

Who is sponsoring clinical trial NCT01334164?

This trial is sponsored by Chestnut Health Systems, which has 20 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01334164 being conducted?

This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT01334164's enrollment target sits among peer trials

480 76th of 2000 higher than 1,924 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01954992 · 480 participants · Phase 3

    Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer

  • NCT03023696 · 480 participants · NA

    Can Prophylactic Foraminotomy Prevent C5 Palsy

  • NCT04948060 · 480 participants · NA

    Tribally Engaged Approaches to Lung Screening (TEALS)

  • NCT05053230 · 480 participants · NA

    A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01334164, the US trial registry maintained by the National Library of Medicine. NCT01334164 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.